Letters, Testimony & Comments

September 29, 2009
RE: SEC Release No. 34-60611 Dear Deputy Secretary Harmon: On behalf of its members, the Biotechnology Industry Organization (“BIO”) is pleased to provide comments on the proposed rulemaking, SEC Release No. 34-60611, by the...
September 28, 2009
Genomic Biomarkers Related to Drug Response.
September 25, 2009
Letter thanking EPA for its work on implementing the Renewable Fuel Standard as passed in the Energy Independence and Security Act of 2007 and for the opportunity to provide comments on the proposed rule as issued.
September 25, 2009
The Biotechnology Industry Organization (BIO) would like to thank the Environmental Protection Agency (EPA) for its work thus far on implementation of the Renewable Fuel Standard (RFS2) as passed in the Energy Independence and Security Act of 2007 (...
September 24, 2009
Comments on the implementation and administration of the Biomass Crop Assistance Program (BCAP)
September 18, 2009
Proposed changes to the Hospital Outpatient Prospective Payment System and CY 2010 payment rates.
September 16, 2009
Letter requesting veto of California Senate Bill 486.
September 9, 2009
Dear Secretary Vilsack: We are writing today to bring to your attention a court case that has the potential to negatively impact the United States' global competitiveness in agriculture. In particular, we are concerned about the possible...
September 3, 2009
Comments in support of USDA's Food Research Initiative.
August 31, 2009
BIO continues to monitor changes to Medicare‘s reimbursement rates and payment policies for their potential impact on innovation and patient access to drugs and biologics. BIO appreciates CMS‘s efforts in the proposed rule to take...
August 31, 2009
Proposed changes to the Hospital Outpatient Prospective Payment System and CY 2010 payment rates.
August 31, 2009
BIO Comments to CMS regarding Proposed Rule CMS-1413-P
August 31, 2009
BIO Comments to CMS regarding Proposed Rule CMS-1414-P